Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Lukoil bought a large office near Belorussky railway station

1/16/25 LKOH

Rusal reduced the vanadium content in aluminum by ten times

1/16/25 RUAL

Rosatom is ready to pay ₽405 mln to bona fide minority shareholders of SMZ

1/16/25 MGNZ

T-Bank launched a loyalty program for shareholders

1/16/25 T

Fesco increased car transportation from China to Russia by 36%

1/16/25 FESH

Novatek's gas sales volume in 2024 decreased by 1.1%

1/16/25 NVTK

MD Medical opened a new clinic in Krasnogorsk

1/16/25 MDMG

Novabev Group shipments decreased by 4.2% in 2024

1/16/25 BELU

Henderson's revenue for 2024 grew 24.2 percent

1/16/25 HNFG

Softline obtained control in K2-9b Group

1/16/25 SOFL